Your browser doesn't support javascript.
loading
Pharmacosimulation of delays and interruptions during administration of tirofiban: a systematic comparison between EU and US dosage regimens.
Heramvand, Nadia; Masyuk, Maryna; Muessig, Johanna M; Nia, Amir M; Karathanos, Athanasios; Polzin, Amin; Valgimigli, Marco; Gurbel, Paul A; Tantry, Udaya S; Kelm, Malte; Jung, Christian.
Affiliation
  • Heramvand N; Department of Medicine, Division of Cardiology, Pulmonary Diseases and Vascular Medicine, University Hospital Düsseldorf, Moorenstraße 5, 40225, Düsseldorf, Germany.
  • Masyuk M; Department of Medicine, Division of Cardiology, Pulmonary Diseases and Vascular Medicine, University Hospital Düsseldorf, Moorenstraße 5, 40225, Düsseldorf, Germany. maryna.masyuk@med.uni-duesseldorf.de.
  • Muessig JM; Department of Medicine, Division of Cardiology, Pulmonary Diseases and Vascular Medicine, University Hospital Düsseldorf, Moorenstraße 5, 40225, Düsseldorf, Germany.
  • Nia AM; Department of Medicine, Division of Cardiology, Pulmonary Diseases and Vascular Medicine, University Hospital Düsseldorf, Moorenstraße 5, 40225, Düsseldorf, Germany.
  • Karathanos A; Department of Medicine, Division of Cardiology, Pulmonary Diseases and Vascular Medicine, University Hospital Düsseldorf, Moorenstraße 5, 40225, Düsseldorf, Germany.
  • Polzin A; Department of Medicine, Division of Cardiology, Pulmonary Diseases and Vascular Medicine, University Hospital Düsseldorf, Moorenstraße 5, 40225, Düsseldorf, Germany.
  • Valgimigli M; Cardiocentro Ticino, Lugano and University of Bern, Bern, Switzerland.
  • Gurbel PA; Sinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore, Baltimore, MD, USA.
  • Tantry US; Sinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore, Baltimore, MD, USA.
  • Kelm M; Department of Medicine, Division of Cardiology, Pulmonary Diseases and Vascular Medicine, University Hospital Düsseldorf, Moorenstraße 5, 40225, Düsseldorf, Germany.
  • Jung C; CARID: Cardiovascular Research Institute Düsseldorf, Düsseldorf, Germany.
J Thromb Thrombolysis ; 54(2): 301-308, 2022 Aug.
Article in En | MEDLINE | ID: mdl-35482154
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Platelet Glycoprotein GPIIb-IIIa Complex / Percutaneous Coronary Intervention Type of study: Guideline / Prognostic_studies Limits: Humans Language: En Journal: J Thromb Thrombolysis Journal subject: ANGIOLOGIA Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Platelet Glycoprotein GPIIb-IIIa Complex / Percutaneous Coronary Intervention Type of study: Guideline / Prognostic_studies Limits: Humans Language: En Journal: J Thromb Thrombolysis Journal subject: ANGIOLOGIA Year: 2022 Document type: Article Affiliation country: Country of publication: